"Pooled Results of Two Randomized Phase III Trials Evaluating VP‑102, a Drug‑Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum"(American Journal of Clinical Dermatology (2021) 22:257–265) and "Comparative efficacy of treatments for molluscum contagiosum: A systematic review and networkmeta-analysis"(JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2023;21:587–597) and "Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis"(eClinicalMedicine 2023;55: 101750)
Dionne Egner
Email: egner@buffalo.edu
Phone: 829-2712